|
卵巢癌抗独特型单链抗体6B11ScFv mGM |
|
刘蓓 崔恒 冯捷 叶雪 李艺 曹善津 葛华 付天云 姚煜 钱和年
【摘要】 目的 构建卵巢癌抗独特型单链抗体6B11ScFv和鼠GM-CSF融合蛋白(6B11mGM),以观察其在动物体内诱导的特异性免疫反应,为卵巢癌抗独特型疫苗应用于临床提供依据。 方法 用DNA重组技术,将mGM-CSF连于单链抗体6B11ScFv羧基末端,构建重组质粒pET30-6B11mGM,转化大肠杆菌BL21(DE3),IPTG诱导,以包涵体形式获高效表达,超声破碎细菌细胞获得包涵体,用8mol.L-1尿素溶解包涵体后直接稀释复性,SDS-PAGE分析蛋白纯度,ELISA分析技术和细胞增殖实验测定融合蛋白的抗体和细胞因子活性。 结果 复性蛋白纯度达90%以上。采用氧化型谷胱甘肽(GSSG)浓度为1mmol.L-1,还原型谷胱甘肽(GSH)浓度为5mmol.L-1,10℃复性48h,复性率达36%。表达的融合蛋白分别能与COC166-9单抗和大鼠抗小鼠GM-CSF单抗特异结合,并能刺激mGM-CSF依赖株NFS-60细胞增殖。 结论 以包涵体表达的融合蛋白6B11mGM保留了两种蛋白的活性,为研究融合蛋白在体内的免疫功能提供了基础。 【关键词】 卵巢癌;重组融合蛋白;抗体;抗独特型;粒细胞-巨噬细胞集落刺激因子;包涵体 【中图分类号】 R392.11 【文献标识码】 A 【文章编号】 0529-1356(2000)03-226
THE CONSTRUCTION, EXPRESSION AND ACTIVITY EXAMINATIONS OF 6B11ScFv/MURINE GM-CSF FUSION PROTEIN
LIU Bei,CUI Heng, FENG Jie, YE Xue, LI YI, CAO Shan-jin, GE Hua, FU Tian-yun, YAO Yu, QIAN He-nian (Gynecologic Oncology Center, People s Hospital, Beijing Medical University, Beijing 100044, China)
【Abstract】 Objective To construct expression vector which expresses fusion protein of antiidiotypic single chain antibody 6B11ScFv and murine GM-CSF(6B11mGM) for observing its possible immune reactions in vivo. Methods Using DNA recombinant techniques, the murine GM-CSF cDNA gene was recombined to 6B11ScFv and they were cloned into expression vector pET-30a(+) to produce insoluble protein. Inclusion bodies collected after the breakage of bacteria through sonication were subjected to repeatedly washing. Inclusion bodies solubilized in the resence of 8 mol.L-1 urea were diluted with renaturation solutions so that folding process could be initiated. The purity was examined by SDS-PAGE, ELISA and cell proliferation assay were used to determine the activities of fusion protein. Results 6B11mGM fusion proteins were obtained with a purity of over 90%. The optimum conditions were 1mmol.L-1 and 5 mmol.L-1 for the concentrations of GSSG and GSH, respectively, with 48 hours at 10℃ as renat[1] [2] [3] 下一页 上一个医学论文: 国内外冠心病的发病现状及其预防对策 下一个医学论文: 抑制cyclinD1表达对乳腺癌细胞增殖及cyclinE CDK2和p21cip1转录的影响
|
|
|
|
|
|
|